Volume 26, Issue 3

Modern biomedical, biotechnology, and pharmaceutical sciences and technology have produced astounding advances and continue to do so. However, these fields are only beginning to grapple with bioethics and patent law intersections, which began with discussions about the morality exception to patentability (a legal standard) and have shifted to ethical licenses (forms of private governance). This …

In 2024, Elon Musk’s company, Neuralink, made headlines with the revelations that it had successfully implanted two patients—both paralyzed due to spinal cord injuries—with “brain-computer interfaces” (“BCIs”): chips designed to give them the ability to use digital devices by thinking alone. While seemingly the stuff of science fiction, implantable technology and wearable devices that monitor …

Artificial intelligence (“AI”) is becoming integral to modern life, fueling innovation while presenting complex legal challenges. Unlike traditional software, AI operates with a degree of autonomy, producing outcomes that its developers or deployers cannot fully anticipate. Advances in underlying technology have further enhanced this autonomy, giving rise to AI agents: systems capable of interacting with …

Most regulatory proposals for social media reform aim to mitigate platforms’ harmful effects without changing their underlying structure. Middleware, by contrast, is a structural solution that aims to create a new competitive layer between dominant internet platforms and consumers. In the context of social media, middleware adoption would mean replacing a platform’s single proprietary recommender …